» Articles » PMID: 25364829

Advanced Glycation End-products Reduce Collagen Molecular Sliding to Affect Collagen Fibril Damage Mechanisms but Not Stiffness

Overview
Journal PLoS One
Date 2014 Nov 4
PMID 25364829
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced glycation end-products (AGE) contribute to age-related connective tissue damage and functional deficit. The documented association between AGE formation on collagens and the correlated progressive stiffening of tissues has widely been presumed causative, despite the lack of mechanistic understanding. The present study investigates precisely how AGEs affect mechanical function of the collagen fibril--the supramolecular functional load-bearing unit within most tissues. We employed synchrotron small-angle X-ray scattering (SAXS) and carefully controlled mechanical testing after introducing AGEs in explants of rat-tail tendon using the metabolite methylglyoxal (MGO). Mass spectrometry and collagen fluorescence verified substantial formation of AGEs by the treatment. Associated mechanical changes of the tissue (increased stiffness and failure strength, decreased stress relaxation) were consistent with reports from the literature. SAXS analysis revealed clear changes in molecular deformation within MGO treated fibrils. Underlying the associated increase in tissue strength, we infer from the data that MGO modified collagen fibrils supported higher loads to failure by maintaining an intact quarter-staggered conformation to nearly twice the level of fibril strain in controls. This apparent increase in fibril failure resistance was characterized by reduced side-by-side sliding of collagen molecules within fibrils, reflecting lateral molecular interconnectivity by AGEs. Surprisingly, no change in maximum fibril modulus (2.5 GPa) accompanied the changes in fibril failure behavior, strongly contradicting the widespread assumption that tissue stiffening in ageing and diabetes is directly related to AGE increased fibril stiffness. We conclude that AGEs can alter physiologically relevant failure behavior of collagen fibrils, but that tissue level changes in stiffness likely occur at higher levels of tissue architecture.

Citing Articles

Understanding molecular mechanism of diabetic wound healing: addressing recent advancements in therapeutic managements.

Porel P, Kaur M, Sharma V, Aran K J Diabetes Metab Disord. 2025; 24(1):76.

PMID: 40060271 PMC: 11883079. DOI: 10.1007/s40200-025-01588-7.


The impact of diabetes mellitus on tendon pathology: a review.

Xu J, Wang J, Ji Y, Liu Y, Jiang J, Wang Y Front Pharmacol. 2024; 15:1491633.

PMID: 39564114 PMC: 11575704. DOI: 10.3389/fphar.2024.1491633.


Long-duration type 1 diabetes is associated with deficient cortical bone mechanical behavior and altered matrix composition in human femoral bone.

Emerzian S, Chow J, Behzad R, Unal M, Brooks D, Wu I J Bone Miner Res. 2024; 40(1):87-99.

PMID: 39561104 PMC: 11700620. DOI: 10.1093/jbmr/zjae184.


Mineral and cross-linking in collagen fibrils: The mechanical behavior of bone tissue at the nano-scale.

Kamml J, Acevedo C, Kammer D J Mech Behav Biomed Mater. 2024; 159:106697.

PMID: 39182252 PMC: 11539549. DOI: 10.1016/j.jmbbm.2024.106697.


Advanced glycation end products mediate biomineralization disorder in diabetic bone disease.

Gao Q, Jiang Y, Zhou D, Li G, Han Y, Yang J Cell Rep Med. 2024; 5(9):101694.

PMID: 39173634 PMC: 11524989. DOI: 10.1016/j.xcrm.2024.101694.


References
1.
Vashishth D, Gibson G, Khoury J, Schaffler M, Kimura J, Fyhrie D . Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone. 2001; 28(2):195-201. DOI: 10.1016/s8756-3282(00)00434-8. View

2.
Eppell S, Smith B, KAHN H, Ballarini R . Nano measurements with micro-devices: mechanical properties of hydrated collagen fibrils. J R Soc Interface. 2006; 3(6):117-21. PMC: 1618494. DOI: 10.1098/rsif.2005.0100. View

3.
Zhou G, Li C, Cai L . Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol. 2004; 165(6):2033-43. PMC: 1618728. DOI: 10.1016/s0002-9440(10)63254-3. View

4.
Siegmund T, Allen M, Burr D . Failure of mineralized collagen fibrils: modeling the role of collagen cross-linking. J Biomech. 2008; 41(7):1427-35. DOI: 10.1016/j.jbiomech.2008.02.017. View

5.
STEGEMANN H, Stalder K . Determination of hydroxyproline. Clin Chim Acta. 1967; 18(2):267-73. DOI: 10.1016/0009-8981(67)90167-2. View